Medtronic (MDT)
85.96
-0.38 (-0.44%)
NYSE · Last Trade: Jun 23rd, 5:36 PM EDT
MEDTRONIC PLC (NYSE:MDT) offers a strong 3.31% dividend yield, reliable payout history, and solid profitability, making it a compelling choice for dividend investors.
Via Chartmill · June 23, 2025
Via The Motley Fool · June 22, 2025
Intuitive Surgical has soared over 150% in three years. But, can the healthcare stalwart overcome tariffs and rising competition to continue winning long-term?
Via MarketBeat · June 19, 2025
Texas Instruments plans to invest $60 billion to expand U.S. chip manufacturing, creating 60,000 jobs. Apple, Ford, Medtronic, NVIDIA, and SpaceX support the initiative.
Via Benzinga · June 18, 2025
The company said its seven factories will span three manufacturing mega-sites and manufacture “hundreds of millions” of U.S.-made chips daily, while creating over 60,000 new U.S. jobs.
Via Stocktwits · June 18, 2025
Intuitive Surgical remains in focus as analysts weigh reprocessing risks after Restore Robotics secures FDA clearance for remanufactured tools.
Via Benzinga · June 13, 2025
Via Benzinga · June 13, 2025
Via The Motley Fool · June 13, 2025
Steady growth and dividend increases over decades can make investors remarkably wealthy.
Via The Motley Fool · June 11, 2025

Via The Motley Fool · June 5, 2025

Via The Motley Fool · June 5, 2025

As firms continue releasing financial results late into the calendar Q1 earnings season, announcements of dividend increases also continue. Some of the latest announcements are particularly notable. This is because several companies that already have high-dividend yield stocks are increasing their quarterly payments even more.
Via MarketBeat · June 2, 2025

MEDTRONIC PLC (NYSE:MDT) offers a solid 3.45% dividend yield with a reliable payout history, strong profitability, and reasonable valuation, making it a compelling choice for dividend investors.
Via Chartmill · June 2, 2025

The company said in a regulatory filing that the decision was made in light of increased clinical and regulatory requirements to maintain regulatory approvals in global markets and to obtain approvals in new regions.
Via Stocktwits · May 28, 2025

The company said the regulatory path forward for one of its key systems is too murky to pursue.
Via Investor's Business Daily · May 28, 2025
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.
Via Benzinga · May 24, 2025
Via The Motley Fool · May 23, 2025
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session.
Via Chartmill · May 22, 2025